NCT07135531Recruiting
Continuous Glucose Monitoring (CGM) in an Underserved Population
Continuous Glucose Monitoring in an Underserved Population: Impact on Glucose Control, Patient Reported Outcomes, Healthcare Utilization, and Long Term Complications
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 14 Aug 2025
- Start date
- 19 Mar 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Tulane University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07135531
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 19 Mar 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently on CGM or using insulin pump
Other illness
- Type 1 diabetes mellitus
Lab values
- Advanced renal disease or Estimated Glomerular Filtration Rate (eGFR) \<40
- The patient has been diagnosed with end-stage renal disease, is on dialysis, or has had a kidney transplant, Hemoglobinopathies, iron therapy or other condition that interferes with HbA1c measurement
Other
- Serious co-morbidities which in the investigator's opinion, will make it challenging for patients to participate
- Pregnant
Who the study is looking for
- Age 18-75 years
- Type 2 diabetes mellitus
- HbA1C ≥ 7.5%
- At least on 1 insulin injection therapy daily
- Patients established with primary care clinic or endocrinology clinic or diabetes clinics in the New Orleans and surrounding areas
- Patients with Medicaid or free care or uninsured
- Patients must be able to speak and understand English and be capable of providing informed consent to participate in the study
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Coordinator of this site? Confirm its status | New Orleans | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.